1h Free Analyst Time
The global glp 1 analogues market is forecasted to grow by USD 100.08 billion during 2024-2029, accelerating at a CAGR of 25.3% during the forecast period. The report on the global glp 1 analogues market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of type 2 diabetes and obesity, growing awareness and diagnosis of metabolic disorders, favorable clinical outcomes and expanding indications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global glp 1 analogues market is segmented as below:
By Application
- Type 2 diabetes mellitus
- Obesity management
- Cardiovascular diseases
By Route Of Administration
- Subcutaneous injection
- Oral administration
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- The Netherlands
- Asia
- Rest of World (RoW)
The report on the global glp 1 analogues market covers the following areas:
- Global glp 1 analogues market sizing
- Global glp 1 analogues market forecast
- Global glp 1 analogues market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2024-2029
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global GLP 1 Analogues Market 2019 - 2023
- Historic Market Size - Data Table on Global GLP 1 Analogues Market 2019 - 2023 ($ million)
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global GLP 1 analogues market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- Threat of new entrants - Impact of key factors in 2024 and 2029
- Threat of substitutes - Impact of key factors in 2024 and 2029
- Threat of rivalry - Impact of key factors in 2024 and 2029
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Type 2 diabetes mellitus - Market size and forecast 2024-2029 ($ million)
- Data Table on Type 2 diabetes mellitus - Market size and forecast 2024-2029 ($ million)
- Chart on Type 2 diabetes mellitus - Year-over-year growth 2024-2029 (%)
- Data Table on Type 2 diabetes mellitus - Year-over-year growth 2024-2029 (%)
- Chart on Obesity management - Market size and forecast 2024-2029 ($ million)
- Data Table on Obesity management - Market size and forecast 2024-2029 ($ million)
- Chart on Obesity management - Year-over-year growth 2024-2029 (%)
- Data Table on Obesity management - Year-over-year growth 2024-2029 (%)
- Chart on Cardiovascular diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiovascular diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiovascular diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiovascular diseases - Year-over-year growth 2024-2029 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Subcutaneous injection - Market size and forecast 2024-2029 ($ million)
- Data Table on Subcutaneous injection - Market size and forecast 2024-2029 ($ million)
- Chart on Subcutaneous injection - Year-over-year growth 2024-2029 (%)
- Data Table on Subcutaneous injection - Year-over-year growth 2024-2029 (%)
- Chart on Oral administration - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral administration - Market size and forecast 2024-2029 ($ million)
- Chart on Oral administration - Year-over-year growth 2024-2029 (%)
- Data Table on Oral administration - Year-over-year growth 2024-2029 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Distribution Channel
10.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- Chart on Spain - Market size and forecast 2024-2029 ($ million)
- Data Table on Spain - Market size and forecast 2024-2029 ($ million)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- Chart on Russia - Market size and forecast 2024-2029 ($ million)
- Data Table on Russia - Market size and forecast 2024-2029 ($ million)
- Chart on Russia - Year-over-year growth 2024-2029 (%)
- Data Table on Russia - Year-over-year growth 2024-2029 (%)
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- Chart on Thailand - Market size and forecast 2024-2029 ($ million)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- Chart on Singapore - Market size and forecast 2024-2029 ($ million)
- Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
- Chart on Singapore - Year-over-year growth 2024-2029 (%)
- Data Table on Singapore - Year-over-year growth 2024-2029 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- Chart on Australia - Market size and forecast 2024-2029 ($ million)
- Data Table on Australia - Market size and forecast 2024-2029 ($ million)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- Chart on South Africa - Market size and forecast 2024-2029 ($ million)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Chart on Turkey - Market size and forecast 2024-2029 ($ million)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Increasing prevalence of type 2 diabetes and obesity
- Growing awareness and diagnosis of metabolic disorders
- Favorable clinical outcomes and expanding indications
- High cost of therapy and reimbursement challenges
- Side effects and patient tolerability
- Competition from pipeline drugs and alternative therapies
- Impact of drivers and challenges in 2024 and 2029
- Development of multi agonist therapies
- Expansion of indications beyond diabetes
- Shift towards oral and longer acting formulations
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key news
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
- Ascendis Pharma AS - Overview
- Ascendis Pharma AS - Product / Service
- Ascendis Pharma AS - Key offerings
- SWOT
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key news
- Boehringer Ingelheim GmbH - Key offerings
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Innovent Biologics Inc. - Overview
- Innovent Biologics Inc. - Product / Service
- Innovent Biologics Inc. - Key offerings
- SWOT
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
- LG Chem Ltd. - Overview
- LG Chem Ltd. - Business segments
- LG Chem Ltd. - Key news
- LG Chem Ltd. - Key offerings
- LG Chem Ltd. - Segment focus
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Takeda Pharmaceutical Ltd. - Overview
- Takeda Pharmaceutical Ltd. - Product / Service
- Takeda Pharmaceutical Ltd. - Key news
- Takeda Pharmaceutical Ltd. - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global GLP 1 Analogues Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on Application - Market share 2024-2029 (%)
Exhibit 39: Data Table on Application - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by Application
Exhibit 41: Data Table on Comparison by Application
Exhibit 42: Chart on Type 2 diabetes mellitus - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Type 2 diabetes mellitus - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Type 2 diabetes mellitus - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Type 2 diabetes mellitus - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Obesity management - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Obesity management - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Obesity management - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Obesity management - Year-over-year growth 2024-2029 (%)
Exhibit 50: Chart on Cardiovascular diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 51: Data Table on Cardiovascular diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 52: Chart on Cardiovascular diseases - Year-over-year growth 2024-2029 (%)
Exhibit 53: Data Table on Cardiovascular diseases - Year-over-year growth 2024-2029 (%)
Exhibit 54: Market opportunity by Application ($ million)
Exhibit 55: Data Table on Market opportunity by Application ($ million)
Exhibit 56: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibit 57: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibit 58: Chart on Comparison by Route of Administration
Exhibit 59: Data Table on Comparison by Route of Administration
Exhibit 60: Chart on Subcutaneous injection - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Subcutaneous injection - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Subcutaneous injection - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Subcutaneous injection - Year-over-year growth 2024-2029 (%)
Exhibit 64: Chart on Oral administration - Market size and forecast 2024-2029 ($ million)
Exhibit 65: Data Table on Oral administration - Market size and forecast 2024-2029 ($ million)
Exhibit 66: Chart on Oral administration - Year-over-year growth 2024-2029 (%)
Exhibit 67: Data Table on Oral administration - Year-over-year growth 2024-2029 (%)
Exhibit 68: Market opportunity by Route of Administration ($ million)
Exhibit 69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 70: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibit 71: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibit 72: Chart on Comparison by Distribution Channel
Exhibit 73: Data Table on Comparison by Distribution Channel
Exhibit 74: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 75: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 76: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 77: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 78: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 79: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 80: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 81: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 82: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 83: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 84: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 85: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 86: Market opportunity by Distribution Channel ($ million)
Exhibit 87: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2024-2029 (%)
Exhibit 90: Data Table on Market share by geography 2024-2029 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 121: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 146: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 147: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 152: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 153: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 154: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 155: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 159: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 160: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 161: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 176: Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 177: Chart on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 178: Data Table on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 189: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 190: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 191: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 192: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 205: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 206: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 207: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 208: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2024 and 2029
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: Amgen Inc. - Overview
Exhibit 219: Amgen Inc. - Product / Service
Exhibit 220: Amgen Inc. - Key news
Exhibit 221: Amgen Inc. - Key offerings
Exhibit 222: SWOT
Exhibit 223: Amneal Pharmaceuticals Inc. - Overview
Exhibit 224: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 225: Amneal Pharmaceuticals Inc. - Key news
Exhibit 226: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 227: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 228: SWOT
Exhibit 229: Ascendis Pharma AS - Overview
Exhibit 230: Ascendis Pharma AS - Product / Service
Exhibit 231: Ascendis Pharma AS - Key offerings
Exhibit 232: SWOT
Exhibit 233: AstraZeneca Plc - Overview
Exhibit 234: AstraZeneca Plc - Product / Service
Exhibit 235: AstraZeneca Plc - Key news
Exhibit 236: AstraZeneca Plc - Key offerings
Exhibit 237: SWOT
Exhibit 238: Boehringer Ingelheim GmbH - Overview
Exhibit 239: Boehringer Ingelheim GmbH - Product / Service
Exhibit 240: Boehringer Ingelheim GmbH - Key news
Exhibit 241: Boehringer Ingelheim GmbH - Key offerings
Exhibit 242: SWOT
Exhibit 243: Eli Lilly and Co. - Overview
Exhibit 244: Eli Lilly and Co. - Product / Service
Exhibit 245: Eli Lilly and Co. - Key offerings
Exhibit 246: SWOT
Exhibit 247: F. Hoffmann La Roche Ltd. - Overview
Exhibit 248: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 249: F. Hoffmann La Roche Ltd. - Key news
Exhibit 250: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 251: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 252: SWOT
Exhibit 253: GlaxoSmithKline Plc - Overview
Exhibit 254: GlaxoSmithKline Plc - Business segments
Exhibit 255: GlaxoSmithKline Plc - Key news
Exhibit 256: GlaxoSmithKline Plc - Key offerings
Exhibit 257: GlaxoSmithKline Plc - Segment focus
Exhibit 258: SWOT
Exhibit 259: Innovent Biologics Inc. - Overview
Exhibit 260: Innovent Biologics Inc. - Product / Service
Exhibit 261: Innovent Biologics Inc. - Key offerings
Exhibit 262: SWOT
Exhibit 263: Johnson and Johnson Services - Overview
Exhibit 264: Johnson and Johnson Services - Business segments
Exhibit 265: Johnson and Johnson Services - Key news
Exhibit 266: Johnson and Johnson Services - Key offerings
Exhibit 267: Johnson and Johnson Services - Segment focus
Exhibit 268: SWOT
Exhibit 269: LG Chem Ltd. - Overview
Exhibit 270: LG Chem Ltd. - Business segments
Exhibit 271: LG Chem Ltd. - Key news
Exhibit 272: LG Chem Ltd. - Key offerings
Exhibit 273: LG Chem Ltd. - Segment focus
Exhibit 274: SWOT
Exhibit 275: Merck and Co. Inc. - Overview
Exhibit 276: Merck and Co. Inc. - Business segments
Exhibit 277: Merck and Co. Inc. - Key news
Exhibit 278: Merck and Co. Inc. - Key offerings
Exhibit 279: Merck and Co. Inc. - Segment focus
Exhibit 280: SWOT
Exhibit 281: Novo Nordisk AS - Overview
Exhibit 282: Novo Nordisk AS - Business segments
Exhibit 283: Novo Nordisk AS - Key offerings
Exhibit 284: Novo Nordisk AS - Segment focus
Exhibit 285: SWOT
Exhibit 286: Sanofi SA - Overview
Exhibit 287: Sanofi SA - Business segments
Exhibit 288: Sanofi SA - Key news
Exhibit 289: Sanofi SA - Key offerings
Exhibit 290: Sanofi SA - Segment focus
Exhibit 291: SWOT
Exhibit 292: Takeda Pharmaceutical Ltd. - Overview
Exhibit 293: Takeda Pharmaceutical Ltd. - Product / Service
Exhibit 294: Takeda Pharmaceutical Ltd. - Key news
Exhibit 295: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 296: SWOT
Exhibit 297: Inclusions checklist
Exhibit 298: Exclusions checklist
Exhibit 299: Currency conversion rates for US$
Exhibit 300: Research methodology
Exhibit 301: Information sources
Exhibit 302: Data validation
Exhibit 303: Validation techniques employed for market sizing
Exhibit 304: Data synthesis
Exhibit 305: 360 degree market analysis
Exhibit 306: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global GLP 1 Analogues Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on Application - Market share 2024-2029 (%)
Exhibit 39: Data Table on Application - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by Application
Exhibit 41: Data Table on Comparison by Application
Exhibit 42: Chart on Type 2 diabetes mellitus - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Type 2 diabetes mellitus - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Type 2 diabetes mellitus - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Type 2 diabetes mellitus - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Obesity management - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Obesity management - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Obesity management - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Obesity management - Year-over-year growth 2024-2029 (%)
Exhibit 50: Chart on Cardiovascular diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 51: Data Table on Cardiovascular diseases - Market size and forecast 2024-2029 ($ million)
Exhibit 52: Chart on Cardiovascular diseases - Year-over-year growth 2024-2029 (%)
Exhibit 53: Data Table on Cardiovascular diseases - Year-over-year growth 2024-2029 (%)
Exhibit 54: Market opportunity by Application ($ million)
Exhibit 55: Data Table on Market opportunity by Application ($ million)
Exhibit 56: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibit 57: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibit 58: Chart on Comparison by Route of Administration
Exhibit 59: Data Table on Comparison by Route of Administration
Exhibit 60: Chart on Subcutaneous injection - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Subcutaneous injection - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Subcutaneous injection - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Subcutaneous injection - Year-over-year growth 2024-2029 (%)
Exhibit 64: Chart on Oral administration - Market size and forecast 2024-2029 ($ million)
Exhibit 65: Data Table on Oral administration - Market size and forecast 2024-2029 ($ million)
Exhibit 66: Chart on Oral administration - Year-over-year growth 2024-2029 (%)
Exhibit 67: Data Table on Oral administration - Year-over-year growth 2024-2029 (%)
Exhibit 68: Market opportunity by Route of Administration ($ million)
Exhibit 69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 70: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibit 71: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibit 72: Chart on Comparison by Distribution Channel
Exhibit 73: Data Table on Comparison by Distribution Channel
Exhibit 74: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 75: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 76: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 77: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 78: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 79: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 80: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 81: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 82: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 83: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibit 84: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 85: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibit 86: Market opportunity by Distribution Channel ($ million)
Exhibit 87: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2024-2029 (%)
Exhibit 90: Data Table on Market share by geography 2024-2029 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 121: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 146: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 147: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 152: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 153: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 154: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 155: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 159: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 160: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 161: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 176: Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 177: Chart on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 178: Data Table on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 189: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 190: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 191: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 192: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 205: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 206: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 207: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 208: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2024 and 2029
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: Amgen Inc. - Overview
Exhibit 219: Amgen Inc. - Product / Service
Exhibit 220: Amgen Inc. - Key news
Exhibit 221: Amgen Inc. - Key offerings
Exhibit 222: SWOT
Exhibit 223: Amneal Pharmaceuticals Inc. - Overview
Exhibit 224: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 225: Amneal Pharmaceuticals Inc. - Key news
Exhibit 226: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 227: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 228: SWOT
Exhibit 229: Ascendis Pharma AS - Overview
Exhibit 230: Ascendis Pharma AS - Product / Service
Exhibit 231: Ascendis Pharma AS - Key offerings
Exhibit 232: SWOT
Exhibit 233: AstraZeneca Plc - Overview
Exhibit 234: AstraZeneca Plc - Product / Service
Exhibit 235: AstraZeneca Plc - Key news
Exhibit 236: AstraZeneca Plc - Key offerings
Exhibit 237: SWOT
Exhibit 238: Boehringer Ingelheim GmbH - Overview
Exhibit 239: Boehringer Ingelheim GmbH - Product / Service
Exhibit 240: Boehringer Ingelheim GmbH - Key news
Exhibit 241: Boehringer Ingelheim GmbH - Key offerings
Exhibit 242: SWOT
Exhibit 243: Eli Lilly and Co. - Overview
Exhibit 244: Eli Lilly and Co. - Product / Service
Exhibit 245: Eli Lilly and Co. - Key offerings
Exhibit 246: SWOT
Exhibit 247: F. Hoffmann La Roche Ltd. - Overview
Exhibit 248: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 249: F. Hoffmann La Roche Ltd. - Key news
Exhibit 250: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 251: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 252: SWOT
Exhibit 253: GlaxoSmithKline Plc - Overview
Exhibit 254: GlaxoSmithKline Plc - Business segments
Exhibit 255: GlaxoSmithKline Plc - Key news
Exhibit 256: GlaxoSmithKline Plc - Key offerings
Exhibit 257: GlaxoSmithKline Plc - Segment focus
Exhibit 258: SWOT
Exhibit 259: Innovent Biologics Inc. - Overview
Exhibit 260: Innovent Biologics Inc. - Product / Service
Exhibit 261: Innovent Biologics Inc. - Key offerings
Exhibit 262: SWOT
Exhibit 263: Johnson and Johnson Services - Overview
Exhibit 264: Johnson and Johnson Services - Business segments
Exhibit 265: Johnson and Johnson Services - Key news
Exhibit 266: Johnson and Johnson Services - Key offerings
Exhibit 267: Johnson and Johnson Services - Segment focus
Exhibit 268: SWOT
Exhibit 269: LG Chem Ltd. - Overview
Exhibit 270: LG Chem Ltd. - Business segments
Exhibit 271: LG Chem Ltd. - Key news
Exhibit 272: LG Chem Ltd. - Key offerings
Exhibit 273: LG Chem Ltd. - Segment focus
Exhibit 274: SWOT
Exhibit 275: Merck and Co. Inc. - Overview
Exhibit 276: Merck and Co. Inc. - Business segments
Exhibit 277: Merck and Co. Inc. - Key news
Exhibit 278: Merck and Co. Inc. - Key offerings
Exhibit 279: Merck and Co. Inc. - Segment focus
Exhibit 280: SWOT
Exhibit 281: Novo Nordisk AS - Overview
Exhibit 282: Novo Nordisk AS - Business segments
Exhibit 283: Novo Nordisk AS - Key offerings
Exhibit 284: Novo Nordisk AS - Segment focus
Exhibit 285: SWOT
Exhibit 286: Sanofi SA - Overview
Exhibit 287: Sanofi SA - Business segments
Exhibit 288: Sanofi SA - Key news
Exhibit 289: Sanofi SA - Key offerings
Exhibit 290: Sanofi SA - Segment focus
Exhibit 291: SWOT
Exhibit 292: Takeda Pharmaceutical Ltd. - Overview
Exhibit 293: Takeda Pharmaceutical Ltd. - Product / Service
Exhibit 294: Takeda Pharmaceutical Ltd. - Key news
Exhibit 295: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 296: SWOT
Exhibit 297: Inclusions checklist
Exhibit 298: Exclusions checklist
Exhibit 299: Currency conversion rates for US$
Exhibit 300: Research methodology
Exhibit 301: Information sources
Exhibit 302: Data validation
Exhibit 303: Validation techniques employed for market sizing
Exhibit 304: Data synthesis
Exhibit 305: 360 degree market analysis
Exhibit 306: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global glp 1 analogues market: Amgen Inc., Amneal Pharmaceuticals Inc., Ascendis Pharma AS, AstraZeneca Plc, Boehringer Ingelheim GmbH, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Innovent Biologics Inc., Johnson and Johnson Services, LG Chem Ltd., Merck and Co. Inc., Novo Nordisk AS, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Ltd., Teva Pharmaceutical Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is development of multi agonist therapies."
According to the report, one of the major drivers for this market is the increasing prevalence of type 2 diabetes and obesity.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc.
- Amneal Pharmaceuticals Inc.
- Ascendis Pharma AS
- AstraZeneca Plc
- Boehringer Ingelheim GmbH
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Innovent Biologics Inc.
- Johnson and Johnson Services
- LG Chem Ltd.
- Merck and Co. Inc.
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Ltd.
- Teva Pharmaceutical Ltd.
